Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M720Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M2.0EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)24.6Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book2.810-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.9PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M4,800,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IHE

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

IHE is held by these investors:

IHE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rapps, MichaelDirector, Director or Senior Officer of 10% Securi 2017-01-16Buy1,200$9.481478.06view
Gridley, Anthony RonaldSenior Officer 2017-01-16Sell1,800$16.94783.12view
Dinwoodie, Tyler Wayne PaulSenior Officer 2017-01-16Buy4,000$0.1787900view
Brown, Mark ThomasDirector 2017-01-16Sell29,300$1.3610900view
Bebek, IvanDirector 2017-01-16Buy8,990$3.384326.04view
smith, laurie james10% Security Holder, Director, Senior Officer 2017-01-16Buy7,500$0.4136387.8view
MEHR, JEFFREYSenior Officer 2017-01-13Sell50,000$27.91436.01view
Squibb, Geoffrey WayneDirector 2017-01-13Buy267$6.272285.96view
Smith, DavidSenior Officer 2017-01-13Sell15,000$60.38147.76view
Rowlands, William BruceDirector, Senior Officer 2017-01-13Buy20,000$0.1599633.33view

Quarterly/Annual Reports about IHE:

    News about IHE:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Should You Buy Pharma ETFs Now? Mar 15 2017
    Johnson & Johnson’s Business Segment Performance Mar 13 2017
    Why Health Care Is The Top Sector Of 2017 Mar 08 2017
    Analysts Scratch Their Heads Over Trump Drug Price Tweet Mar 07 2017
    Trump Tweets And Drug Stocks Fall Mar 07 2017
    Healthcare ETFs in Focus on Obamacare Replacement Plan Mar 07 2017
    Trump's Latest Drug Pricing Tweet Hits Biotech Stocks Mar 07 2017
    How These Recent Developments Could Affect Mylan Mar 06 2017
    Pfizer’s Products with Falling Revenues in 4Q16 Feb 27 2017
    Wall Street Analysts’ Estimates for Merck & Co. Feb 24 2017
    Merck & Co. Reported Flat Operational Revenues in 4Q16 Feb 22 2017
    Q4 Earnings Faring Well for Pharma ETFs Feb 06 2017
    Novartis’s 4Q16 Earnings Meet Analysts’ Estimates Feb 01 2017
    How to Play Pfizer's Fourth-Quarter Results With ETFs Feb 01 2017
    Eliquis: Bristol-Myers Squibb’s Key Cardiovascular Drug Jan 31 2017
    Bristol-Myers Squibb: 4Q16 Earnings Show Growth Jan 30 2017
    What Are Analysts’ Future Estimates for Johnson & Johnson? Jan 30 2017
    Johnson & Johnson Reports Growth in 4Q16 Jan 26 2017
    How Did JNJ’s Pharmaceuticals Segment Perform in 4Q16? Jan 20 2017
    What Lies Ahead for Pharma ETFs? Jan 19 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)